Skip to content

Feasibility of the Cochlear™ Nucleus® Cochlear Implant in a Newly Implanted Adult Population

Feasibility of the Cochlear™ Nucleus® Cochlear Implant in a Newly Implanted Adult Population.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618001593224
Enrollment
10
Registered
2018-09-25
Start date
2018-09-10
Completion date
2020-02-28
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of the feasibility study is to examine speech perception outcomes (quiet and noise) and safety (adverse events and adverse device effects) with the cochlear implant in eleven newly implanted adults who meet the eligibility criteria for the study.

Interventions

Cochlear Prosthesis Implantation. All participants will receive the same treatment- implantation of the totally implantable cochlear implant TI1012 (surgery) and over night stay in hospital. ENT surgeon will administer the intervention and will be follow up up by Audiologists in Cochlear clinic There will be a 2 week gap from implantation (surgery) to activation at the clinic

Sponsors

Cochlear Ltd
Lead SponsorCommercial sector/Industry

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. A bilateral or unilateral moderately severe to profound postlinguistic sensorineural hearing loss and who have compromised functional hearing with hearing aids or receive no benefit with hearing aids. 2. Fluent speaker in the local language used to assess clinical performance as judged by the investigator. 3. Eighteen years of age or older at the time of enrolment with no upper age limit. 4. A 30 day trial and/or experience with appropriately fit hearing aids.

Exclusion criteria

1. Deafness due to lesions of the acoustic nerve or central auditory pathway. 2. Active middle-ear infections. 3. Tympanic membrane perforation. 4. Ossification, malformation or any other cochlear anomaly, such as common cavity, that might prevent complete insertion of the electrode array, as confirmed by medical examination. 5. Evidence of severe-to-profound hearing loss prior to 5 years of age. 6. Pre-existing cochlear or bone conduction implant. 7. Medical or psychological conditions that contraindicate general anaesthesia or surgery. 8. Additional disabilities that may affect the subject’s participation or safety during the clinical investigation. 9. Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations that are inherent to the surgical procedure(s) and prosthetic devices as determined by the Investigator. 10. Unwillingness or inability of the candidate to comply with all investigational requirements as determined by the Investigator. 11. Existing CSF shunts or drains, existing perilymph fistula, skull fracture or CSF leaks 12. Recurrent episodes of bacterial meningitis. 13. Pre-existing skin condition that could jeopardize wound healing as judged by the investigator e.g. psoriasis, dermatitis, use of corticosteroids, uncontrolled diabetes. 14. Pre-existing medical condition that requires serial MRI and CT. 15. Pre-existing medical condition of peripheral neuropathy.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026